![Researchers found EZH2 overexpression to be an indicator of poor prognosis in synovial sarcomas Researchers found EZH2 overexpression to be an indicator of poor prognosis in synovial sarcomas](https://blog.bjbms.org/wp-content/uploads/2019/01/Sarcoma-Team-326x245.jpg)
Author Summary
Researchers found EZH2 overexpression to be an indicator of poor prognosis in synovial sarcomas
Synovial sarcoma (SS) is a rare malignant tumor of the young adults, usually located in deep-soft tissue. It is rare, but unfortunately fatal. The peak incidence is at 15-40 years of age, and affects mostly […]